4 ms·
Their patent isn't on technique ("method" in the ruling), but on the actual cDNA sequence itself. As such, it's specific to the two BRCA genes. Of course, tha
by tomku 13y ago
Their patent isn't on technique ("method" in the ruling), but on the actual cDNA sequence itself. As such, it's specific to the two BRCA genes.
Of course, that just makes it even more ridiculous.
- unmei 13y agoI guess my question is, do they still have a patent on any BRCA1/2 cDNA or only that specifically created according to their method?
- tomku 13y agoAccording to the ruling, their patent specifies a sequence of nucleotides of cDNA independent of any method used to create them. I read that to mean that any BRCA1 or BRCA2 cDNA that matches that exact sequence would be infringing on Myriad's patent, regardless of how it was created.